Related Experiment Video
Updated: Jun 29, 2026

05:44
Arthroscopic Excision of Posterior Cruciate Ligament Cysts Using a Double Posteromedial Approach
Published on: October 20, 2023
Retrograde approach for complex popliteal and tibioperoneal occlusions
Miguel Montero-Baker1, Andrej Schmidt, Sven Bräunlich
1Department of Medicine I, Angiology/Cardiology, Park Hospital, University of Leipzig Heart Center, Leipzig, Germany.
Summary
The retrograde approach offers a safe and effective method for treating complex popliteal and tibioperoneal occlusions when antegrade attempts fail. This technique can significantly reduce treatment failure rates in patients with critical limb ischemia.
Area of Science:
- Vascular Surgery
- Endovascular Interventions
- Peripheral Artery Disease
Background:
- Complex popliteal and tibioperoneal occlusions present a significant challenge in endovascular treatment.
- Antegrade revascularization approaches have limitations and can fail in a notable percentage of cases.
Purpose of the Study:
- To detail the technical aspects of the retrograde approach for endovascularly treating complex popliteal and/or tibioperoneal occlusions.
- To evaluate the efficacy of the retrograde approach in reducing endovascular treatment failure rates.
Main Methods:
- An observational registry of retrograde revascularizations was analyzed over 14 months.
- The study included patients whose antegrade revascularization attempts for complex occlusions failed.
- Treatments were performed via percutaneous transpedal access or transcollateral intra-arterial techniques.
Main Results:
- The retrograde approach achieved an overall success rate of 86.3% (44/51 limbs).
- Adjunctive stenting was required in 41.1% of cases to optimize outcomes.
- Major complications were low (1.9%), with only one pedal access site occlusion reported.
Conclusions:
- The retrograde approach is a feasible and safe adjunct for complex popliteal to infrapopliteal occlusions when antegrade attempts fail.
- This technique can effectively modify and reduce failure rates in challenging cases.
- Further large-scale studies are needed to confirm long-term safety, efficacy, and clinical benefits for critical limb ischemia patients.